European specialist investor GHO Capital Partners has announced the sale of its portfolio company, VISUfarma, a pan-European specialty pharmaceutical company focused on ophthalmology, to global pharma major Lupin, at an…
The Netherlands: Lupin strengthens ophthalmology business with acquisition of VISUfarma from GHO Capital
…
…



